Incidence and Time Trends in Hodgkin's Disease: from Parts of the United Kingdom (1984-1993)

Cartwright, R. A.; McNally, Richard J.Q.; Roman, Eve; Simpson, Jill; Thomas, Julia

doi:10.3109/10428199809059230

Cited by 11 publications

(14 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The incidence of HL in Australia was stable during 1982–1996, a finding broadly consistent with stable or declining HL incidence observed in the United Kingdom (1984–1993), Nordic countries (1978–97), Europe (1983–1997;1985–1992), and the United States (1969–1984; 1992–2001) . In the subsequent 10‐year period, 1997–2006, HL incidence increased in Australia.…”

Section: Discussionsupporting

confidence: 68%

“…Classification changes resulting in shifts in the distribution of cutaneous T-cell lymphoma subtypes may have contributed to this pattern. 41 The incidence of HL in Australia was stable during 1982-1996, a finding broadly consistent with stable or declining HL incidence observed in the United Kingdom (1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992)(1993), 42 Nordic countries (1978-97), 43 Europe (198343 Europe ( -19971985, 7,14 and the United States (1969-1984; 1992-2001). 3,44 In the subsequent 10-year period, 1997-2006, HL incidence increased in Australia.…”

Section: Discussionsupporting

confidence: 58%

See 1 more Smart Citation

Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006

Leeuwen

Turner

Joske

et al. 2014

Intl Journal of Cancer

View full text Add to dashboard Cite

There are limited data characterizing the subtype-specific incidence of lymphoid neoplasms in the World Health Organization (WHO) Classification era. Data were obtained on all incident lymphoid neoplasms registered in Australia during . Subtypes were grouped using the InterLymph nested hierarchical classification, based on the 2008 WHO Classification. Temporal trends were examined using Joinpoint regression; average annual percentage change in incidence was computed. Multiple Poisson regression was used to compare incidence by sex and age. The incidence of all non-Hodgkin lymphoma (NHL) increased by 2.5%/year during 1982-1996 and was stable thereafter. During 1997During -2006, several mature B-and natural killer (NK)-/T-cell NHL subtypes increased in incidence, including diffuse large B-cell (1.3%/year), follicular (2.5%/year), Burkitt (6.8%/year), marginal zone (13.2%/year), mantle cell (4.2%/year), peripheral T-cell lymphoma (4.7%/year) and plasmacytoma (7.1%/year). While chronic lymphocytic leukemia incidence was stable, small lymphocytic lymphoma incidence declined (8.1%/year). Hodgkin lymphoma (HL) incidence increased during 1997-2006 (2.2%/year), both classical (4.3%/year) and nodular lymphocyte predominant (12.1%/year) HL. Diagnostic artifact, evidenced by a sustained decline in the incidence of NHL not otherwise specified (NOS; 5.8%/year) and lymphoid neoplasms NOS (5.6%/year), limits the interpretation of temporal trends for some subtypes. A marked male predominance was observed for almost all subtypes. Incidence of mature B-and NK-/T-cell NHL subtypes increased sharply with age, except for Burkitt lymphoma/leukemia. For HL subtypes, a bimodal age distribution was only evident for nodular sclerosis HL. Variation in incidence patterns over time and by sex and age supports etiological differences between lymphoid neoplasm subtypes.Lymphoid neoplasms, including non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), plasma cell neoplasms and lymphoid leukemias, collectively represent the fifth most common malignancy in Australia. 1 Their etiology is largely unknown, with specific infections and immunodeficiency being the only established risk factors. Descriptive studies in the United States and Europe show differences in demographic 2-4 and temporal 3,5 incidence patterns between lymphoid neoplasm subtypes, which, together with observations from analytical studies, 6 suggest differences in etiology.There have been few comprehensive studies of subtypespecific incidence patterns. [2][3][4]7 The existence of multiple classification schemes 8 and variable exclusion criteria make comparisons challenging. These schemes include the Working Formulation (WF, 1982), the Revised European-American Lymphoma (REAL) Classification (1994) and the World Health Organization (WHO) Classification of Tumours of

show abstract

Section: Discussionsupporting

confidence: 68%

Section: Discussionsupporting

confidence: 58%

Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006

Leeuwen

Turner

Joske

et al. 2014

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Why this is and what risk factors might be involved and how they link with these differences in trend is not apparent. There have been suggestions of occupational male exposure and female risks associated with childlessness (Cartwright et al , 1998), but none of these are particularly convincing, and there is also evidence for infectious agents which are, in some instances, known to affect the sexes differently (unpublished observations).…”

Section: Overview Of Results Of Trend Studiesmentioning

confidence: 99%

“…The specialist U.K. registry (Cartwright et al , 1997) has analysed recent changes of HD and found them to be as complex as those for routine registrations noted above. The study was based on over 3000 cases for the period 1984–93 (Cartwright et al , 1998). The salient results are shown in Table IV, where changes by age, sex and subtype are given.…”

Section: Time Trends By Disease Typementioning

confidence: 99%

Time Trends in Incidence of Haematological Malignancies and Related Conditions

Cartwright¹,

Gilman²,

Gurney³

1999

Br J Haematol

View full text Add to dashboard Cite

“…In elderly rather a decreasing tendency was found, which was explained by the development of diagnostical methods [21]. A trial between 1984 and 1993 in the United Kingdom found the decrease of the incidence in both sexes, in every age groups, except for males between 1 and 24 [22]. Investigating seven European countries no changes was found in the incidence between 1985 and 1992 [23].…”

Section: Discussionmentioning

confidence: 99%

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary

et al. 2011

View full text Add to dashboard Cite

Introduction. Hodgkin lymphoma shows a well-known geographic pattern, but temporal changes have been found recently as well. Patients and Methods. 439 Hodgkin lymphoma patients' clinicopathological and treatment data were processed in calendar periods of approximately ten years. The patients were treated at our department from 1980 until the end of 2008. Results. The first period (1980–89) contained 177 patients, the second (1990–99) 147, and the third (2000–08) 115 Hodgkin lymphoma patients. The mean age of the patients was 40.1, 35.9, and 36.8 years in order. The male/female ratio: 1.42, 1.45, 1.05 in order. Contrary-wise a unimodal age group pattern could have been seen with an incidence peak between 30 and 39 in the past decades. The incidence of classical mixed cellularity histological subtype is decreasing (43.7%, 58.23%, 42.6%, P = 0.0098 (it is only significant in the second period)); classical nodular sclerosis shows an increasing tendency (25%, 27.32%, 34.78%, P = 0.1734). The first incidence peak is predominantly created by classical nodular sclerosis, meanwhile the second peak by classical mixed cellularity. The number of early-stage patients (59.12%) is beyond the advanced stage (40%) in the last decade. Meanwhile, the number of second-stage patients was increasing (25.8%, 26.35%, 49.56% P < 0.0001) and of patients in third stage was decreasing (53.4 %, 50.67%, 20% P < 0.0001). The 5- and 10-year overall survival data were progressing: 59.7 %, 77.4 %, and 90.5 % and 44.1 %, 70.6 % and 90.5 % (expected survival) in the last decade. Conclusions. Changes can be explained by the altered nature of Hodgkin lymphoma, the changes in socioeconomic status and the development of diagnostic and therapy methods.

show abstract

Incidence and Time Trends in Hodgkin's Disease: from Parts of the United Kingdom (1984-1993)

Cited by 11 publications

References 22 publications

Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006

Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006

Time Trends in Incidence of Haematological Malignancies and Related Conditions

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary

Contact Info

Product

Resources

About